הלוואות ואשראי לטווח ארוך של החברה: Avid Bioservices, Inc (CDMO)

Avid Bioservices, Inc. (CDMO) is developing partnerships with biotech centers to optimize the production of biologics and accelerate their commercialization. Business growth is driven by capacity expansion and high outsourcing demand from startups, while long-term debt stands at 0.21. This price chart on the GURU.Markets platform illustrates the asset value dynamics of this biologics developer.

This indicator aggregates liabilities with maturities exceeding one year, reacting to strategic borrowings intended for asset modernization. The metric determines financial leverage and the cost of capital servicing over the long term. For Avid Bioservices, Inc. (CDMO), such investments are critical when expanding capacity to meet strict FDA regulations. Effective backlog management allows for the optimization of the debt load. By analyzing the dynamics of the business's long-term borrowed capital, an investor assesses the sustainability of the company's expansion.